Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia

Journal of Rheumatology

Volumn 31, Issue 6, 2004, Pages 1152-1158

  Lin, Kuan Chia ^a,b   Tsao, Hsuan Ming ^a,c   Chen, Chen Huan ^a,c   Chou, Pesus ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cardiovascular diseases; Hypertension; Hyperuricemia

Indexed keywords

GLUCOSE; URIC ACID;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FOLLOW UP; GLUCOSE BLOOD LEVEL; GOUT; HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERURICEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

ADULT; ARRHYTHMIA; ARTERIOSCLEROSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERURICEMIA; INCIDENCE; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; URIC ACID;

EID: 2642542362     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Brand FN, McGee DL, Kannel WB, Stokes J, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: The Framinghan Study. Am J Epidemiol 1985;121:11-8.
2. Klein R, Klein BE, Cornoni JC, Maready J, Cassel JC, Tyroler HA. Serum uric acid: Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med 1973;132:401-10.
3. Ward HJ. Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998;352:670-1.
4. Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart disease, The Framingham Study. J Clin Epidemiol 1988;41:237-42.
5. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med 1999;131:7-13.
6. Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart 1997;78:147-53.
7. Yano K, Reed DM, McGee DL. Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics. Am J Epidemiol 1984;119:653-66.
8. Rich MW. Uric acid: is it a risk factor for cardiovascular disease? Am J Cardiol 2000;85:1018-21.
9. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality. The NHANES I Epidemiologic Follow-up Study, 1971-1992. JAMA 2000;283:2404-10.
10. Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999;34:144-50.
11. Wannamethee SG. Is serum uric acid a risk factor for coronary heart disease? J Human Hypertens 1999;13:153-6.
12. Leyva F, Anker S, Swan JW, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997;18:858-65.
13. Nieto FJ, Iribarren C, Gross MD, Cornstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 2000;148:131-9.
14. Puig JG, Ruilope LM. Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens 1999;17:869-72.
15. Iribarren C, Sharp DS, Curb JD, Yano K. High uric acid: a metabolic marker of coronary heart disease among alcohol abstainers? J Clin Epidemiol 1996;49:73-8.
16. Staessen J, for members of the European Working Party on High Blood Pressure in the Elderly. The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial. Am J Med 1991;90:50S-54S.
17. Lin KC, Lin HY, Chou P. Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol 2000;27:1045-50.
18. Lin KC, Lin HY, Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol 2000;27:1501-5.
19. Chou P, Liao MJ, Kuo HS, Hsiao KJ, Tsai ST. A population survey on the prevalence of diabetes in Kin-Hu, Kinmen. Diabetes Care 1994;17:1055-8.
20. Chen CH, Lin HC, Kuo HS, Chang MS, Chou P. Epidemiology of hypertension in Kin-Hu, Kinmen. Am J Hypertens 1995;8:395-403.
21. Chen CH, Chuang JH, Kuo HS, Chang MS, Wang SP, Chou P. A population-based epidemiological study on cardiovascular risk factors in Kin-Chen, Kinmen. Int J Cardiol 1995;48:75-88.
22. Chen CH, Lin KC, Tsai ST, Chou P. Different association of hypertension and insulin-related metabolic syndrome between men and women in 8437 nondiabetic Chinese. Am J Hypertens 2000;13:846-53.
23. Li CL, Tsai ST, Chou P. Comparison of metabolic risk profiles between subjects with fasting and 2-hour plasma glucose impairment - the Kinmen Study. J Clin Epidemiol 2002;55:19-24.
24. Chou P, Lin KC, Lin HY, Tsai ST. Gender differences in the relationships of serum uric acid with fasting serum insulin and fasting plasma glucose in non-diabetic subjects. J Rheumatol 2001;28:571-6.
25. Chou P, Li CL, Wu GS, Tsai ST. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Diabetes Care 1998;21:1183-7.
26. Chou P, Liao MJ, Kuo HS, et al. Program description and preliminary health survey data in Kin-Hu, Kinmen. Chin Med J Taipei 1993;52:241-8.
27. Chou P, Kuo HS, Chen CC, Lin HC. Characteristics of non-participants and reasons for non-participation in a population survey in Kin-Hu, Kinmen. Eur J Epidemiol 1997;13:195-200.
28. Furberg CD, Manolio TA, Psaty BM, et al. Major electrocardiographic abnormalities in persons agd 65 years and older (the Cardiovascular Health Study). Am J Cardiol 1992;69:1329-35.
29. Kannel WB. The Framingham experience. In: Marmot M, Elliott P, editors. Coronary heart disease epidemiology - from aetiology to public health. New York: Oxford University Press; 1992:66-82.
30. Darmawan J, Valkenburg HA, Muirden KD, Wigley RD. The epidemiology of gout and hyperuricemia in a rural population of Java. J Rheumatol 1992;19:1595-9.
31. Prior IA, Rose BS, Harvey HP, Davidson F. Hyperuricemia, gout and diabetic abnormality in Polynesian people. Lancet 1966;1:333-8.
32. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
33. Anon. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46. Erratum in: Arch Intern Med 1998;158:573.
34. Anon. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46. Erratum in: Arch Intern Med 1998;158:573.
35. Wyngaarden JB, Kelley WN. Gout and hyperuricemia, New York: Grune and Stratton; 1976:134-6.
36. Becker MA, Levinson D. Clinical gout and pathogenesis of hyperuricemia. In: Koopman WJ, editor. Arthritis and allied conditions. 13th ed. Baltimore: Williams & Wilkins; 1996.
37. Hall AP, Barry PE, Dawber TR, McNamara PM. Epidemiology of gout and hyperuricemia. Am J Med 1967;42:27-37.
38. Zavaroni I, Mazza S, Fantuzzi M, et al. Changes in insulin and lipid metabolism in males with asymptomatic hyperuricemia. J Intern Med 1993;234:25-30.
39. Duffy WB, Senekjian HO, Knight TF, Weinman EJ. Management of asymptomatic hyperuricemia. JAMA 1981;246:2215-6.
40. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia: risks and consequences in the Normative Aging Study. Am J Med 1987;82:421-6.
41. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991;266:3008-11.
42. Cappuccio FP, Strazzullo P, Farinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA 1993;270:354-9.
43. Ward HJ. Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998;352:670-1.
44. Jossa F, Farinaro E, Panico S, et al. Serum uric acid and hypertension: the Olivetti Heart Study. J Hum Hypertens 1994;8:677-81.
45. Selby JV, Friedman GD, Quesenberry CP. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990;131:1017-27.
46. Anon. Ventricular extrasystoles during thiazide treatment: substudy of MRC mild hypertension trial. BMJ (Clin Res Ed) 1983;287:1249-53.
47. McDonald CJ, Hui SL, Tierney WM, Diuretic-induced laboratory abnormalities that predict ventricular ectopy. J Chron Dis 1986;39:127-35.
48. Altup S, Demiryurek AT, Ak D, Tungel M, Kanzik I, Contribution of peroxynitrite to the beneficial effects of preconditioning on ischaemia-induced arrhythmias in rat isolated hearts, Eur J Pharmacol 2001;16:239-46.
49. Lehto S, Niskanen L, Ronnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1998;29:635-9.